Before You Buy an Aesthetic Laser: 10 Questions Every Med Spa Owner Should Ask
There are some incredible aesthetic devices on the market right now. Technology is getting better, treatment categories continue to expand, and patients are increasingly interested in everything from skin quality and collagen stimulation to resurfacing, tightening, pigmentation, vascular concerns, hair removal, body treatments and combination treatment plans.
For the right practice, the right technology can be an excellent investment. It can open a new revenue stream, allow you to treat concerns you previously had to refer out, increase patient retention, expand lifetime patient value and give your providers more tools to build comprehensive treatment plans.
So let me be very clear: I am not anti-device.
I spent years selling aesthetic technology before moving into consulting. I know what good technology can do clinically, and I have watched practices build extremely successful revenue streams around the right equipment.
What I am against is making a six-figure capital decision without doing six-figure due diligence.
Because a great laser can still be a terrible business decision.
And your laser rep's ROI calculator is not your business plan.
The Laser Purchase Usually Isn't the Problem. The Decision-Making Process Is.
I have seen this play out from both sides of the table.
An owner sees an impressive demonstration. The before-and-afters are beautiful. The technology fills several treatment categories. The sales representative walks through the revenue potential and shows how quickly the monthly payment could theoretically be covered. There may be a trade-in allowance, special financing, quarter-end pricing or an incentive that creates a legitimate reason to make a decision quickly.
None of those things inherently makes the device—or the salesperson—bad.
The sales representative's job is to demonstrate the clinical capabilities and commercial potential of the technology.
The owner's job is to determine whether that potential translates into a viable business case inside their specific practice.
Those are two different jobs.
The problem starts when the sales presentation becomes the entire due-diligence process.
A projection showing what a device can generate is not the same thing as determining what it can realistically generate with your patient base, your pricing, your staffing, your available treatment hours, your marketing capabilities and your existing technology.
Before you sign anything, you should be able to successfully argue the business case for the purchase using your own numbers, your own patients and your own market.
Start with these ten questions.
1. What Business Problem Is This Device Actually Solving?
Before you ask which laser you should buy, ask why you are shopping for one in the first place.
Maybe you have significant demand for resurfacing and currently refer those patients elsewhere. Perhaps you have built a successful injectable practice but know you need stronger skin-quality options to create more comprehensive treatment plans. Your estheticians may have reached the limit of what they can address without energy-based technology. Your existing device may be outdated, unreliable or too limited. You may have identified a real treatment category that is underserved in your local market.
All of those could support a legitimate business case.
But “I saw this machine at a conference and it was amazing” is not yet a business case.
Neither is “the med spa down the street just bought one.”
Define the problem first. Then evaluate which technologies solve it.
Otherwise, you are shopping backward: choosing a machine and then trying to invent the business need that justifies buying it.
2. Is There Real Demand in Your Patient Base?
One of the best market-research tools available to you isn't a national industry report. It is your own patient database.
Look at what your patients are already telling you. Review consultation notes, lost opportunities, requests your front desk receives, services you refer elsewhere and concerns your providers hear repeatedly.
Before purchasing, you should be able to answer questions such as:
How many existing patients realistically fit the treatment profile?
What concerns are we currently unable to address well?
How often are patients asking about this treatment category?
Are we currently referring revenue elsewhere?
Which of our existing patient groups could logically move into this treatment?
Would this technology deepen existing patient relationships, or require us to acquire an entirely new type of patient?
Is the demand for the clinical outcome, or merely awareness of a particular device brand?
That last question matters.
Patients might not walk in asking for an erbium laser, a specific wavelength or a particular RF platform. They may simply be saying, “My skin looks crepey,” “I hate these brown spots,” “I don't want filler but I want to look better,” or “I want to improve my skin texture.”
Your job is to understand the demand behind the treatment—not just whether patients recognize the machine's name.
3. What Technology Do You Already Own—and How Well Are You Using It?
Before adding another monthly payment, audit the technology already sitting inside your practice.
This is one of the least glamorous parts of device purchasing, and one of the most important.
Pull actual utilization. How many treatments has each device performed over the last 30, 60 and 90 days? How many treatment hours are realistically available? Which providers use the equipment consistently? Which ones rarely recommend it? Which indications perform well? Which ones barely move?
If you discover that you already own hundreds of thousands of dollars in technology operating at a fraction of capacity, that should change the purchasing conversation.
The solution may not be another device. You may have a consultation problem, a training problem, a pricing problem, a provider-confidence problem, a treatment-planning problem or a marketing problem.
You may also discover that the existing equipment simply wasn't the right purchase in the first place.
Either way, another machine does not automatically solve an utilization problem.
Understanding why your current technology is or isn't performing gives you enormously valuable information about what needs to be different before the next purchase.
4. Does the Business Case Work Before You Buy An Aesthetic Laser?
This is where I want owners to become much more rigorous.
A manufacturer's ROI model can be useful because it helps illustrate the economics of the technology. But it is still a model.
Your job is to replace its assumptions with your reality.
A real business case should account for considerably more than the monthly equipment payment. At minimum, I want an owner to understand:
Purchase price and financing structure
Monthly payment
Consumables and disposable costs
Service contract and warranty costs
Expected maintenance expenses
Provider labor
Treatment-room time
Marketing expense
Training costs
Average treatment price
Package pricing and discounts
Realistic treatment volume
Break-even volume
Target profit margin
Expected ramp-up period
Then stress-test it.
If you need 15 treatments per month to produce the return you want, where are those 15 treatments coming from?
Do you have sufficient provider capacity? Enough treatment-room availability? Enough existing candidates? A consultation process capable of converting them? A marketing plan capable of supplementing that demand?
If the projection works only when every assumption goes perfectly, it isn't a very strong projection.
And if your ROI requires you to perform 15 treatments a month when your realistic capacity supports 5, you don't have an ROI model.
You have wishful thinking in spreadsheet form.
If you are buying an aesthetic laser, this is one of the areas I evaluate in the Apex Laser Purchase Readiness Assessment: whether the projected treatment volume, pricing, costs and patient demand actually support the investment before an owner signs the contract.
Book your Laser Purchase Readiness Assessment - as an Apex VIP, use code Laser50 to save!
5. Who Is Actually Going to Perform—and Recommend—the Treatments?
Before purchasing, you need to identify exactly who will perform the treatment, whether they can legally do so in your state, whether they have the capacity to absorb the volume and whether they actually want to use the technology.
I have seen owners purchase equipment based largely on the enthusiasm of one provider. Six months later, that employee leaves and the entire revenue strategy walks out the door with them.
That risk should be considered before the purchase, not after.
Devices don't generate revenue. People do.
Think beyond basic technical training. Your providers also need to understand who is a candidate, how to explain the treatment, how it compares with other modalities in the practice, how to set realistic expectations and when not to recommend it.
The same goes for your front-desk and patient-coordination teams. They may not perform the procedure, but they absolutely influence whether a prospective patient ever makes it into the treatment room.
Your device strategy has to belong to the practice, not one employee.
6. How Does the Device Fit Into Your Existing Treatment Plans?
This may be the biggest missed opportunity I see in practices that already own good technology.
They treat every service as its own department.
Injectables are over here. Lasers are over there. Esthetics lives somewhere else. Skincare is at the front desk. Each provider understands and recommends the services they personally perform.
The patient, however, did not walk in with departmental concerns.
She walked in saying that she looks tired. Her skin is changing. She hates her pigmentation. She wants better texture. She wants to age well without looking overdone.
That patient does not need your device menu.
She needs a treatment strategy.
Before purchasing a new technology, determine where it fits within the clinical pathways you already offer. For example:
How would resurfacing complement injectables?
Where does IPL fit into a pigment or redness plan?
When should RF microneedling be recommended instead of—or alongside—other collagen-stimulating treatments?
How does medical-grade skincare prepare or maintain the result?
Which patients could appropriately move between esthetics, lasers and injectables over the course of a year?
The strongest device purchase doesn't merely give you another treatment to sell.
It makes the rest of your practice more useful.
7. What Is the Plan After the Launch Event?
New-device launches can create an artificial sense of permanent demand.
The machine arrives. Everyone is excited. The representative is onsite. You send an email blast, offer introductory pricing, invite your best patients, post repeatedly on social media and fill several days with treatments.
That's great.
But what happens 90 days later?
Long-term utilization requires a system. Before purchase, you should know how the treatment will be incorporated into everyday patient conversations, how providers will identify candidates, how your team will explain it and how it becomes part of ongoing treatment planning.
Your implementation strategy should address things like:
Launch marketing
Existing-patient reactivation
Consultation scripts
Treatment-plan integration
Packages or series pricing
Before-and-after photography
Provider and front-desk education
Email and social content
Monthly utilization targets
Ownership of follow-up
30-, 60- and 90-day performance reviews
The purchase is not the implementation plan.
The implementation plan should exist before the purchase.
8. What Does the Competitive Landscape Really Look Like?
Competitive analysis matters, but not because you should make purchasing decisions based on what another med spa owns.
If six practices within five miles already offer a similar technology, that does not automatically mean there is no opportunity. It does mean you need to understand the market you're entering.
Look at how comparable treatments are priced, how competitors position them, whether they rely heavily on discounts, what their reviews say and how saturated the category appears to be. Determine whether your opportunity comes from unmet demand, better clinical expertise, a stronger patient experience, more comprehensive treatment planning or a genuinely differentiated technology.
And be cautious about overvaluing exclusivity.
Being the only practice in town with a specific machine can absolutely help with positioning. But devices can be purchased by competitors too.
A machine is not a brand strategy.
Your longer-term differentiation comes from what your team does with the technology, the results you produce, the experience surrounding it and how intelligently it fits into the rest of the patient's care.
9. What Happens If Your Assumptions Are Wrong?
Every owner wants to model the upside of a purchase.
Smart owners model the downside too.
Run the uncomfortable scenarios before signing:
What if treatment volume is 25–30% lower than projected?
What if the primary provider leaves?
What if you need considerably more marketing spend than expected?
What if the average selling price ends up lower than your model?
What happens when the warranty expires?
What if the device is down for two weeks?
What does the service agreement actually cover?
Can the financing agreement be transferred?
What is the resale market?
What happens if a newer technology changes consumer demand?
This isn't being pessimistic.
It's basic risk management.
You do not need an investment to be risk-free. No business investment is. You do need to understand the risk you're accepting and determine whether the potential return justifies it.
10. Would You Still Buy It Without the Deadline?
Quarter-end pricing. Trade-show pricing. Demo-unit pricing. Special financing. An additional discount approved by a manager. A trade-in allowance that supposedly expires Friday.
I know these conversations extremely well, hell I invented a few.
Sometimes the financial opportunity is real. Timing a purchase strategically can absolutely save a practice money, and there is nothing wrong with negotiating aggressively when you have already decided that a technology is right for you.
But there is a critical difference between using a promotion to improve the economics of a good decision and using a promotion to justify a decision you weren't ready to make.
Ask yourself one question:
If the device was full price, would I still want it?
If the answer is no—or you're not sure—keep doing your homework.
A six-figure investment deserves a better rationale than “They gave me $20,000 off.”
Saving $20,000 on the wrong $150,000 purchase isn't saving money. It's spending $130,000 BADLY.
What a Successful Device Business Case Should Tell You
By the time you're ready to make a decision, you should be able to explain the purchase without relying on the salesperson's pitch.
You should be able to clearly articulate:
Why this technology: What clinical or business gap it solves.
Why this patient population: Who will buy the treatment and how you know the demand exists.
Why this practice: Why it fits your positioning, menu, team and existing technology.
Why now: Why the timing makes sense strategically—not just promotionally.
Why this price: What the real financial commitment is and how it compares with alternatives.
How it will generate revenue: Including realistic volume, pricing, costs and break-even assumptions.
Who owns implementation: From training and marketing to utilization and reporting.
How success will be measured: At 30, 60 and 90 days, then six, 12 and 24 months.
If you can make that argument convincingly, then you are no longer buying a shiny machine.
You're making a capital investment. And that distinction matters.
Sometimes the Right Answer Is Yes
I don't want owners to finish this article afraid to purchase technology.
Quite the opposite.
There are practices right now that should be investing in a device. They have strong demand, available provider capacity, an obvious treatment gap, healthy cash flow, an under-served market and an existing patient population ready for a more comprehensive treatment approach.
For those practices, waiting indefinitely can be just as poor a business decision as buying impulsively.
Due diligence isn't designed to talk you out of purchasing.
It is designed to make you confident that you can successfully argue why you should.
Sometimes the answer will be, Yes, this is exactly what the practice needs.
Sometimes it will be, Yes, but this isn't the right technology.
Sometimes it will be, The device is right, but the financing isn't.
And sometimes the answer will be, Not yet. We need to fix utilization, consultation conversion or staffing first.
Every one of those conclusions is more valuable than finding out the answer six months after the machine arrives.
Before Buying an Aesthetic Laser, Assess the Practice
That is exactly why I created the Apex Laser Purchase Readiness Assessment.
I spent years in aesthetic laser sales. Today, I sit on the other side of that table helping owners make the business decision behind the technology. I don't have a device to sell you, a quota to hit or a manufacturer I need you to choose.
The goal of the Laser Purchase Readiness Assessment is not to tell you which machine I personally like.
It is to give you the tools and independent analysis necessary to determine which investment makes sense for your practice.
We look at the business behind the potential purchase, including your existing equipment, patient demand, treatment mix, competitive market, team readiness, pricing, financial assumptions, treatment integration and the operational realities that ultimately determine whether a technology succeeds after it arrives.
Because there are plenty of excellent aesthetic devices on the market.
Your job isn't simply to find a great device. Your job is to find the right investment for your practice.
If you're considering buying an aesthetic laser, do the due diligence before the contract is sitting in front of you and the clock is supposedly ticking on the price.
Book your Apex Laser Purchase Readiness Assessment and build the business case before you buy the machine. Don't forget code Laser50, good until 10/31/26.
Comments